Dachaigh › Myelofibrosis › Utah › Salt Lake City
Sgrùdaidhean clionaigeach Myelofibrosis ann an Salt Lake City, UT
Tha 10 sgrùdaidhean airson Myelofibrosis a’ lorg phàirtichean aig làraichean ann agus timcheall air Salt Lake City (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
A’ fastadhÌre 1/2
- Huntsman Cancer Institute, Salt Lake City
Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis
A’ fastadhÌre 1
- Huntsman Cancer Institute at University of Utah, Salt Lake City
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
A’ fastadhÌre 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
A’ fastadhÌre 1
- Huntsman Cancer Institute At University of Utah, Salt Lake City
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
A’ fastadhÌre 1
- Huntsman Cancer Institute, Salt Lake City
AlloHCT With PegINFa for Myelofibrosis
A’ fastadhÌre 1
- Huntsman Cancer Institute at the University of Utah, Salt Lake City
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
A’ fastadhÌre 1
- University of Utah, Salt Lake City
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
A’ fastadhÌre 2
- Huntsman Cancer Institute, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Salt Lake City
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
A’ fastadhÌre 3
- University of Utah, Huntsman Cancer Institute, Salt Lake City
Sgrùdaidhean Myelofibrosis ann am bailtean eile
- Houston, TX19 sgrùdaidhean
- New York City, NY18 sgrùdaidhean
- Boston, MA12 sgrùdaidhean
- Durham, NC12 sgrùdaidhean
- Columbus, OH11 sgrùdadh
- Seattle, WA11 sgrùdadh
- Miami, FL10 sgrùdaidhean
- Atlanta, GA9 sgrùdaidhean
- Baldwin Park, CA9 sgrùdaidhean
- Nashville, TN9 sgrùdaidhean
- Tampa, FL9 sgrùdaidhean
- Cleveland, OH9 sgrùdaidhean
Sgrùdaidhean eile ann an Salt Lake City
- Aillse Sgamhain Neo-chealla-beag31 sgrùdaidhean
- Aillse (gach seòrsa)27 sgrùdaidhean
- Aillse a' bhroilleach27 sgrùdaidhean
- Aillse colorectal22 sgrùdaidhean
- Ailseachadh nan Sgamhan21 sgrùdaidhean
- Melanoma21 sgrùdaidhean
- Myeloma iomaill21 sgrùdaidhean
- Ailse metastatach20 sgrùdaidhean
- Cancer Ovarian19 sgrùdaidhean
- Obesity18 sgrùdaidhean
- Leukemia myeloid geur17 sgrùdaidhean
- Fàilligeadh a' Chridhe17 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.